[HTML][HTML] Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress …
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related …
WC Lin, YL Chiu, KL Kuo, PM Chow… - … journal of cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
[PDF][PDF] Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress …
WC Lin, YL Chiu, KL Kuo, PM Chow, CH Hsu, SM Liao… - atmosphere - e-century.us
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related …
T Jung, F Shun - AMERICAN JOURNAL OF CANCER …, 2023 - nckur.lib.ncku.edu.tw
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks
significant advance-ments in treatment methods. However, PR-619, a novel inhibitor of …
significant advance-ments in treatment methods. However, PR-619, a novel inhibitor of …
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related …
WC Lin, YL Chiu, KL Kuo, PM Chow… - American Journal of …, 2023 - europepmc.org
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma
through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis …
through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis …
[引用][C] Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress …
WC Lin, YL Chiu, KL Kuo, PM Chow, CH Hsu, SM Liao… - atmosphere - europepmc.org
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …
significant advancements in treatment methods. However, PR-619, a novel inhibitor of …